Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GenMark Diagnostics Inc. GNMK

Healthcare
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

Mid-Afternoon Market Update: KEYW Drops Following Disappointing Q3 Results; Varonis Shares Surge

Benzinga.com  November 3, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of World Acceptance Corporation (WRLD)

PR Newswire November 3, 2017

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against RE/MAX Holdings, Inc.

Business Wire November 3, 2017

GenMark Diagnostics Reports Third Quarter 2017 Results

Business Wire November 2, 2017

GenMark Diagnostics, Inc. to Host Earnings Call

Accesswire November 2, 2017

GenMark Diagnostics Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017

Business Wire October 19, 2017

Today's Research Report Coverage on Medical Equipment Stocks -- AcelRx Pharma, GenMark Diagnostics, ViewRay, and Nevro

PR Newswire September 25, 2017

Mid-Afternoon Market Update: Crude Oil Down 2.5%; Horizon Global Shares Spike Higher

Benzinga.com  August 1, 2017

15 Biggest Mid-Day Losers For Tuesday

Benzinga.com  August 1, 2017

Mid-Day Market Update: Pitney Bowes Drops On Earnings Miss; Lumber Liquidators Shares Climb

Benzinga.com  August 1, 2017

GenMark Reports Second Quarter 2017 Results

Business Wire August 1, 2017

Investor Network: GenMark Diagnostics, Inc. to Host Earnings Call

Accesswire August 1, 2017

GenMark Diagnostics to Attend Canaccord Genuity’s 37th Annual Growth Conference

Business Wire July 31, 2017

GenMark Achieves CE Mark for its ePlex® Blood Culture Identification Gram-Positive and Gram-Negative Panels

Business Wire June 29, 2017

GenMark Diagnostics Prices Upsized Public Offering of Common Stock

Business Wire June 13, 2017

GenMark Diagnostics Commences Public Offering of Common Stock

Business Wire June 12, 2017

GenMark Receives FDA 510(k) Market Clearance for Its ePlex® Instrument and Respiratory Pathogen Panel

Business Wire June 12, 2017

GenMark Diagnostics to Present at the 2017 William Blair Growth Stock Conference

Business Wire May 31, 2017

GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

Business Wire May 3, 2017

GenMark Diagnostics Reports First Quarter 2017 Results

Business Wire May 2, 2017